SCHEMBL25314535

SCHEMBL25314535

COC(=O)c1ccc2c(C)cc(OS(=O)(=O)C(F)(F)F)cc2c1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NOTUM Q6P988 2/20 0.45
LCK P06239 1/20 0.43
STS P08842 1/20 0.40
CYP2C9 P11712 4/20 0.39
ALDH1A1 P00352 3/20 0.39
TSHR P16473 1/20 0.39
NPSR1 Q6W5P4 1/20 0.39
PTPN11 Q06124 2/20 0.39
KDM4E B2RXH2 1/20 0.38
LMNA P02545 1/20 0.38
HTT P42858 1/20 0.38
L3MBTL1 Q9Y468 1/20 0.38
RAB9A P51151 1/20 0.38
GAA P10253 1/20 0.37
VCAM1 P19320 1/20 0.37
CA12 O43570 1/20 0.37
CA1 P00915 1/20 0.37
CA2 P00918 1/20 0.37
CA7 P43166 1/20 0.37
XDH P47989 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3316267 0.84 STS (0.49) NOTUMLCKSTSALDH1A1PTPN11
SCHEMBL2113911 0.82 STS (0.47) NOTUMLCKSTSALDH1A1PTPN11
SCHEMBL25313411 0.81 CA1 (0.51) LCKCYP2C9ALDH1A1TSHRNPSR1
SCHEMBL13057679 0.78 STS (0.44) STSALDH1A1PTPN11KDM4ERAB9A
SCHEMBL7345215 0.78 NOTUM (0.64) NOTUMSTSCYP2C9ALDH1A1TSHR
SCHEMBL14616750 0.78 NOTUM (0.53) NOTUMSTSCYP2C9ALDH1A1TSHR
SCHEMBL10030428 0.78 NOTUM (0.48) NOTUMLCKCYP2C9ALDH1A1TSHR
SCHEMBL10073218 0.77 CYP3A4 (0.49) NOTUMSTSALDH1A1LMNAGAA
SCHEMBL18198487 0.77 LCK (0.48) NOTUMLCKSTSCYP2C9ALDH1A1
SCHEMBL4391166 0.76 NOTUM (0.45) NOTUMSTSALDH1A1TSHRKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250084062-A1 SUBSTITUTED QUINOLINE DERIVATIVE ASTELLAS PHARMA INC. (JP) 2025-03-13 US disclosed
CN-118488952-A Substituted quinoline derivatives 安斯泰来制药有限公司 2024-08-13 CN disclosed
WO-2023127814-A1 SUBSTITUTED QUINOLINE DERIVATIVE ASTELLAS PHARMA INC. (JP) 2023-07-06 WO disclosed
WO-2023127814-A1 SUBSTITUTED QUINOLINE DERIVATIVE ASTELLAS PHARMA INC. (JP) 2023-07-06 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250084062-A1 SUBSTITUTED QUINOLINE DERIVATIVE CHRNA4, CHRNA2, CHRNA5 NOTUM 495/4885LCK 3244/4885STS 3533/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.